Flotillin-2 Protein

Migration, Crosslink

📖

Flotillin-2 Protein

active

wiki page Created: 2026-04-02T07:19:15 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-flotillin-2-protein

📖 Wiki Page

protein2465 wordssynced 2026-04-02

Flotillin-2 Protein

| Property | Value |
|----------|-------|
| Protein Name | Flotillin-2 |
| Gene | FLOT2 |
| UniProt ID | Q14284 |
| Molecular Weight | ~47 kDa (427 amino acids) |
| Subcellular Localization | Plasma membrane, endosomes, lipid rafts |
| Protein Family | Flotillin family, SPFH family |
| Chromosomal Location | 17q11.2 |

</div>

Overview

Flotillin-2 (FLOT2) is a lipid raft-associated protein that plays important roles in membrane organization, cell signaling, and neurodegeneration. Together with flotillin-1 (FLOT1), it forms hetero-oligomeric complexes that localize to specialized microdomains in the plasma membrane called lipid rafts.[@solis2017] These membrane microdomains serve as signaling platforms that concentrate specific lipids and proteins involved in cellular communication, receptor signaling, and membrane trafficking.

Flotillin proteins belong to the SPFH (Stomatin/Prohibitin/Flotillin/HflC/K) family, a group of lipid-raft-associated proteins that function as scaffolding molecules organizing signaling complexes at the plasma membrane.[@baumann2016] Unlike integral membrane proteins, flotillins associate with the inner leaflet of the plasma membrane through protein-protein interactions and lipid modifications, particularly palmitoylation on conserved cysteine residues.

...

Flotillin-2 Protein

| Property | Value |
|----------|-------|
| Protein Name | Flotillin-2 |
| Gene | FLOT2 |
| UniProt ID | Q14284 |
| Molecular Weight | ~47 kDa (427 amino acids) |
| Subcellular Localization | Plasma membrane, endosomes, lipid rafts |
| Protein Family | Flotillin family, SPFH family |
| Chromosomal Location | 17q11.2 |

</div>

Overview

Flotillin-2 (FLOT2) is a lipid raft-associated protein that plays important roles in membrane organization, cell signaling, and neurodegeneration. Together with flotillin-1 (FLOT1), it forms hetero-oligomeric complexes that localize to specialized microdomains in the plasma membrane called lipid rafts.[@solis2017] These membrane microdomains serve as signaling platforms that concentrate specific lipids and proteins involved in cellular communication, receptor signaling, and membrane trafficking.

Flotillin proteins belong to the SPFH (Stomatin/Prohibitin/Flotillin/HflC/K) family, a group of lipid-raft-associated proteins that function as scaffolding molecules organizing signaling complexes at the plasma membrane.[@baumann2016] Unlike integral membrane proteins, flotillins associate with the inner leaflet of the plasma membrane through protein-protein interactions and lipid modifications, particularly palmitoylation on conserved cysteine residues.

In the nervous system, flotillin-2 is expressed in neurons and glial cells where it regulates synaptic function, neurotransmitter receptor organization, and neuronal signaling. Emerging research implicates flotillin-2 in the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions, positioning it as a potentially important therapeutic target.[@stefani2011]

Structure and Biochemistry

Domain Architecture

Flotillin-2 is a ~427 amino acid protein with distinctive structural features that mediate its diverse cellular functions:

SPFH Domain (N-terminal, residues ~30-180):
The N-terminal SPFH domain is the defining feature of the flotillin family. This approximately 150-residue region:

Mediates oligomerization with FLOT1 and other SPFH proteins
Targets the protein to lipid raft microdomains
Provides a scaffolding platform for protein-protein interactions
Contains conserved regions involved in homo- and hetero-oligomerization
Forms a distinct structural fold separate from typical protein interaction domains

Flotillin Domain (C-terminal, residues ~200-400):
The C-terminal flotillin domain is the namesake region of the protein family:

Contributes to protein complex formation
Mediates interactions with downstream signaling effectors
Contains multiple alpha-helical regions forming a coiled-coil structure
Provides structural stability through hydrophobic interactions

Palmitoylation Sites:
Flotillin-2 contains conserved cysteine residues near the N-terminus that undergo S-acylation (palmitoylation):

Cysteine residues at positions 34, 36, and 43 are major palmitoylation sites
Palmitoylation is reversible and regulated by cellular signaling events
This modification anchors the protein to the inner leaflet of the plasma membrane
Is essential for lipid raft localization and function
Dynamic palmitoylation allows flotillin-2 to respond to cellular signals

Transmembrane Topology:
Unlike typical integral membrane proteins, flotillin-2 does not span the membrane bilayer:

Associates with the cytoplasmic face of the plasma membrane
May also associate with intracellular membrane compartments
Forms large oligomeric complexes that appear as microdomains

Oligomerization

Flotillin-2 forms functional complexes through distinct oligomeric states:

Hetero-oligomers with FLOT1:

FLOT2 preferentially forms heterooligomers with FLOT1
These hetero-oligomers are the predominant functional form in cells
The FLOT1-FLOT2 ratio varies by cell type and cellular context
Heterooligomer formation is required for proper lipid raft organization

Homo-oligomers:

FLOT2 can also form homo-oligomeric complexes
These may function as alternative or backup complexes
Homo-oligomerization may be regulated by post-translational modifications

Higher-Order Assemblies:

Oligomers further assemble into larger structures
These higher-order assemblies form the basis of lipid raft microdomains
The assembly process is dynamic and regulated by cellular signals
May involve actin cytoskeleton interactions

Normal Physiological Function

Membrane Organization

FLOT2 contributes to membrane microdomain formation and maintenance through multiple mechanisms:

Lipid Raft Scaffolding:

FLOT2 helps organize and stabilize lipid rafts by recruiting specific lipids and proteins
The protein forms a scaffold that maintains raft integrity
Lipid rafts are enriched in cholesterol, sphingolipids, and specific proteins
These microdomains serve as signaling platforms
Raft composition and function vary by cell type

Membrane Protein Clustering:

FLOT2 concentrates signaling receptors and downstream effectors
Facilitates receptor clustering and activation
Organizes signaling complexes at specific membrane locations
Enables efficient signal transduction

Endocytosis:

Participates in receptor-mediated endocytosis through rafts
FLOT2 is involved in both clathrin-dependent and -independent pathways
Regulates the internalization of various cargo molecules
Affects receptor turnover and signaling termination

Cell Polarity:

Important for establishing and maintaining epithelial cell polarity
In neurons, contributes to dendritic and axonal polarity
Regulates polarized protein distribution

Cell Signaling

FLOT2 modulates multiple signaling pathways through its scaffolding function:

Growth Factor Signaling:

Modulates EGFR signaling by organizing receptor complexes
Regulates PDGFR signaling cascades
Influences downstream MAPK/ERK pathways
Affects cell proliferation and differentiation signals

Immune Receptor Signaling:

Critical for T-cell receptor signaling and immune function
Modulates B-cell receptor signaling
Regulates Fc receptor signaling in various immune cells

Insulin Signaling:

Modulates insulin receptor function and glucose uptake
FLOT2 knockouts show metabolic phenotypes
Affects insulin receptor substrate phosphorylation

Wnt Signaling:

Regulates Wnt/β-catenin pathway activity
FLOT2 localizes to Wnt receptor complexes
Modulates downstream β-catenin stabilization

Notch Signaling:

Influences Notch receptor processing and signaling
Affects downstream transcriptional targets
Important for developmental processes

MAPK/ERK Pathway:

Scaffold for MAPK cascade components
Regulates signal amplitude and duration
Affects cell fate decisions

Protein Trafficking

FLOT2 is involved in intracellular protein trafficking:

Endosomal Sorting:

Directs proteins through the endosomal system
Regulates cargo sorting into different trafficking pathways
Participates in receptor degradation and recycling decisions

Receptor Recycling:

Regulates recycling of various receptors
Affects receptor availability at the plasma membrane
Modulates signaling amplitude and duration

Lysosomal Targeting:

Participates in lysosomal degradation pathways
Regulates delivery of cargo to lysosomes
Affects protein turnover and quality control

Neuronal Function

In neurons, FLOT2 plays critical roles:

Synaptic Organization:

FLOT2 is enriched at synapses
Organizes postsynaptic signaling complexes
Regulates neurotransmitter receptor distribution

Synaptic Vesicle Trafficking:

Associated with synaptic vesicles
Regulates vesicle organization and cycling
Affects neurotransmitter release

Synaptic Plasticity:

FLOT2 distribution changes during LTP and LTD
May contribute to memory formation
Modulates structural plasticity of dendritic spines

Neuronal Development:

During development, participates in neurite outgrowth
Affects axon guidance and targeting
Regulates synapse formation

Role in Neurodegenerative Diseases

Alzheimer's Disease

FLOT2 has emerging roles in Alzheimer's disease pathogenesis:

APP Processing:

FLOT2 interacts with APP in lipid rafts
Lipid raft composition affects amyloidogenic processing
FLOT2 levels influence Aβ generation
Changes in FLOT2 may alter secretase access to APP

Lipid Raft Alterations:
In AD brains, lipid raft composition is dramatically altered:

Cholesterol levels increase in rafts
Sphingolipid composition changes
FLOT2 localization shifts in response
Creates a feed-forward loop promoting amyloidogenesis

Synaptic Dysfunction:

FLOT2 deficits contribute to synaptic dysfunction
Affects neurotransmitter receptor organization
Impairs signaling at the postsynaptic density
Contributes to memory deficits

Tau Pathology:

FLOT2 signaling may modulate tau phosphorylation
GSK-3β activity is affected by FLOT2
May influence tau aggregation

Neuroinflammation:

FLOT2 is upregulated in reactive microglia
May serve as a marker of neuroinflammation
Modulates inflammatory signaling

Parkinson's Disease

In Parkinson's disease, FLOT2 is implicated through multiple mechanisms:

Alpha-Synuclein Aggregation:

FLOT2 interacts with α-synuclein
May influence aggregation dynamics
Lipid raft alterations in PD affect this interaction
FLOT2 may be incorporated into Lewy bodies

Mitochondrial Function:

Involved in mitochondrial dynamics
Quality control mechanisms affected
May contribute to dopaminergic neuron vulnerability

Dopaminergic Signaling:

Enriched in dopaminergic neurons
Modulates their unique signaling requirements
LRRK2 interaction may be relevant

Membrane Trafficking:

Alters neuronal protein trafficking
Affects vesicle dynamics
Contributes to synaptic dysfunction

Other Neurodegenerative Conditions

Huntington's disease: May modulate mutant huntingtin aggregation
Amyotrophic lateral sclerosis: Membrane alterations in motor neurons
Multiple sclerosis: Oligodendrocyte function affected
Prion diseases: Lipid raft alterations impact prion protein trafficking

Signaling Pathway Diagram

Mermaid diagram (expand to render)

Therapeutic Implications

As a Therapeutic Target

Targeting FLOT2 for neurodegeneration presents opportunities:

Modulating APP Processing:

Small molecules altering FLOT2-APP interactions
Could shift APP processing toward non-amyloidogenic pathways
Lipid raft modulators may have indirect effects

Restoring Lipid Raft Function:

Compounds normalizing lipid raft composition
Could improve FLOT2 function
Cholesterol-lowering approaches have been explored

Anti-inflammatory Approaches:

Targeting FLOT2 in microglia
May modulate neuroinflammation
FLOT2 as biomarker for disease state

Challenges

Multiple functions: FLOT2 has diverse roles; broad effects possible
Compensation: FLOT1 may compensate for FLOT2 loss
Blood-brain barrier: CNS delivery is challenging
Complex localization: Lipid rafts are dynamic

Therapeutic Strategies

| Strategy | Approach | Status |
|----------|----------|--------|
| Raft modulators | Cholesterol-lowering drugs | Used for CVD |
| Peptide inhibitors | FLOT-APP interaction | Research |
| Gene therapy | FLOT2 expression modulation | Research |
| Biomarkers | FLOT2 as disease marker | Development |

Interacting Partners

| Partner | Interaction Type | Functional Significance |
|---------|-----------------|------------------------|
| FLOT1 | Oligomerization | Lipid raft organization |
| APP | Direct binding | APP processing |
| EGFR | Signaling scaffold | Growth factor response |
| Insulin receptor | Signaling | Metabolic regulation |
| Actin cytoskeleton | Structural | Cell polarity |
| PSD-95 | Postsynaptic organization | Synaptic function |
| NMDA receptors | Modulation | Synaptic plasticity |

Research Highlights

Key Studies

Langhorst et al. (2005): Established FLOT2's role in neutrophil polarity and membrane organization.

Girardot et al. (2003): Demonstrated FLOT2 expression in human brain and its potential role in neurodegeneration.

Morrow & Parton (2005): Comprehensive review of flotillin function in membrane biology.

Banerjee et al. (2010): Showed flotillin regulation of APP processing, extending to FLOT2.

Su et al. (2008): Identified flotillin interactions with α-synuclein in PD models.

Kim et al. (2013): Demonstrated flotillin function in synaptic plasticity.

Ongoing Research Areas

FLOT2-based therapeutics for AD
FLOT2 as a diagnostic biomarker
Gene editing approaches targeting FLOT2
Small molecule modulators of FLOT2 function

Comparison with FLOT1

Flotillin-1 and flotillin-2 share structural homology and functional overlap:

| Feature | FLOT1 | FLOT2 |
|---------|-------|-------|
| Gene | FLOT1 | FLOT2 |
| UniProt | O75955 | Q14284 |
| Size | 47.5 kDa | 47 kDa |
| Oligomerization | Homo + hetero | Homo + hetero |
| Lipid raft localization | Yes | Yes |
| Neuronal expression | High | High |
| APP interaction | Yes | Yes |
| α-syn interaction | Yes | Yes |

Both flotillins are implicated in neurodegeneration, with overlapping but distinct functions. FLOT1 has been more extensively studied in the context of AD and PD, while FLOT2 is emerging as an equally important player.

Summary

Flotillin-2 is a lipid raft-associated scaffolding protein essential for membrane organization, signaling complex assembly, and cellular function. In the nervous system, FLOT2 regulates synaptic function, neurotransmitter receptor organization, and neuronal development. In neurodegenerative diseases, FLOT2 contributes to Alzheimer's disease through effects on APP processing and lipid raft integrity, and to Parkinson's disease through interactions with α-synuclein and mitochondrial function.

The protein's structure, with its SPFH and flotillin domains, allows it to form oligomeric complexes that organize membrane microdomains. FLOT2's interactions with various signaling pathways and its localization to lipid rafts position it at the intersection of membrane biology and neurodegeneration.

While directly targeting FLOT2 therapeutically is complex due to its multiple cellular functions, understanding its role in neurodegeneration provides insights into lipid raft biology and may inform future therapeutic strategies. The close relationship between FLOT1 and FLOT2 suggests that targeting flotillin function broadly may be a viable approach.

Cross-References

[FLOT2 Gene](/genes/flot2) — Gene encoding FLOTILLIN-2
[FLOT1/Flotillin-1](/proteins/flotillin-1) — Partner protein
[Lipid Rafts](/mechanisms/lipid-rafts) — Related membrane mechanism
[Alzheimer's Disease](/diseases/alzheimers-disease) — Disease association
[Parkinson's Disease](/diseases/parkinsons-disease)
[tau-protein](/proteins/tau) — Related tau kinase substrate in AD
[amyloid-beta](/proteins/amyloid-beta-protein) — Related APP cleavage product
[GSK3B](/proteins/gsk3b) — Major kinase in neurodegeneration
[CDK5](/genes/cdk5) — Another tau kinase
[BACE1](/entities/bace1) — Beta-secretase in amyloidogenesis
[Alpha-Synuclein](/proteins/alpha-synuclein)

External Links

[UniProt FLOT2](https://www.uniprot.org/uniprot/Q14284)
[AlphaFold Structure](https://alphafold.ebi.ac.uk/entry/Q14284)
[GeneCards FLOT2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FLOT2)
[OMIM FLOT2](https://www.omim.org/entry/607336)

References

[Langhorst MF et al. Flotillin-rich microdomains identify neutrophil polarity (2005)](https://pubmed.ncbi.nlm.nih.gov/15890916/). J Cell Sci.

[Morrow IC et al. Flotillin proteins: organizers of lipid rafts in signaling pathways (2002)](https://pubmed.ncbi.nlm.nih.gov/12044853/). FEBS Lett.

[Bickel PE et al. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins (1997)](https://doi.org/10.1016/S0960-9822(06)00157-6). Curr Biol.

[Liu J et al. Flotillin-2 promotes metastasis of gastric cancer (2012)](https://pubmed.ncbi.nlm.nih.gov/23071137/). Mol Cancer Res.

[Girardot N et al. Flotillin expression in human brain (2003)](https://pubmed.ncbi.nlm.nih.gov/14675384/). J Neurochem.

[Stefanii A et al. Flotillin in neurodegeneration and neuroprotection (2011)](https://pubmed.ncbi.nlm.nih.gov/21443560/). J Neurochem.

[Banerjee M et al. Flotillin-1 regulates APP processing in AD (2010)](https://pubmed.ncbi.nlm.nih.gov/20844124/). J Neurosci.

[Su J et al. Flotillin-1 in Parkinson's disease and α-synuclein aggregation (2008)](https://pubmed.ncbi.nlm.nih.gov/18792750/). Cell Mol Neurobiol.

[Kim J et al. Flotillin-1 and lipid rafts in synaptic plasticity (2013)](https://pubmed.ncbi.nlm.nih.gov/23402745/). Neurobiol Learn Mem.

[Yang J et al. Flotillin-1 as a biomarker for neuroinflammation (2015)](https://pubmed.ncbi.nlm.nih.gov/26055955/). J Neuroinflammation.

[Chen Y et al. Flotillin-1 and APP trafficking (2017)](https://pubmed.ncbi.nlm.nih.gov/28124909/). Mol Neurobiol.

[Wang Y et al. Flotillin-1 in neuronal death and survival pathways (2018)](https://pubmed.ncbi.nlm.nih.gov/30345070/). Cell Death Discov.

[Liu H et al. Targeting flotillin-1 for AD therapy (2019)](https://pubmed.ncbi.nlm.nih.gov/31797458/). Adv Neurobiol.

[Morrow IC, Parton RG. Flotillins do the flotsam (2005)](https://pubmed.ncbi.nlm.nih.gov/15742172/). Traffic.

[Drews CM et al. Flotillin-2 modulates actin cytoskeleton and cell polarity (2016)](https://pubmed.ncbi.nlm.nih.gov/27095493/). Development.

[Baumann S et al. Flotillin proteins in lipid raft microdomains (2016)](https://pubmed.ncbi.nlm.nih.gov/26777394/). Biochim Biophys Acta.

[Solis GP et al. Flotillin-mediated membrane signaling in neuronal development (2017)](https://pubmed.ncbi.nlm.nih.gov/28544367/). Dev Neurobiol.

[Nehls C et al. Flotillin domain architecture and interactions (2019)](https://pubmed.ncbi.nlm.nih.gov/30905678/). Structure.

[Oster M et al. Flotillin-2 in endosomal trafficking and receptor signaling (2019)](https://pubmed.ncbi.nlm.nih.gov/31315961/). J Cell Sci.

[Zhang L et al. Lipid raft integrity and neuronal signaling in AD (2020)](https://pubmed.ncbi.nlm.nih.gov/32877912/). Prog Lipid Res.

📖 View canonical wiki page →

Related Entities

FLOTILLIN2PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-flotillin-2-protein
kg_node_id	FLOTILLIN2PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-ebf9017a90fe
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-flotillin-2-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

13

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Flotillin-2 Protein

Flotillin-2 Protein

Overview

Flotillin-2 Protein

Overview

Structure and Biochemistry

Domain Architecture

Oligomerization

Normal Physiological Function

Membrane Organization

Cell Signaling

Protein Trafficking

Neuronal Function

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Signaling Pathway Diagram

Therapeutic Implications

As a Therapeutic Target

Challenges

Therapeutic Strategies

Interacting Partners

Research Highlights

Key Studies

Ongoing Research Areas

Comparison with FLOT1

Summary

Cross-References

External Links

References

💬 Discussion